ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,607Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 625

$868K Total Retail Price of All Prescriptions

Rank: 45 out of 625

666 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 666 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 666 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 11,683 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 663 562 1 2
HYDROCODONE-ACETAMINOPHEN 645 391 S3 2 4
LEVOTHYROXINE SODIUM 630 541 3 3
AMLODIPINE BESYLATE 611 531 4 1
OMEPRAZOLE 448 364 5 6
LOSARTAN POTASSIUM 364 313 6 18
FUROSEMIDE 337 301 7 7
METOPROLOL TARTRATE 330 303 8 11
ZOLPIDEM TARTRATE 275 230 9 13
LISINOPRIL 271 198 10 5
ATORVASTATIN CALCIUM 257 183 11 9
METFORMIN HCL 241 198 12 10
PRAVASTATIN SODIUM 217 169 13 8
CARVEDILOL 211 197 14 23
GABAPENTIN 201 145 15 14
HYDROCHLOROTHIAZIDE 191 160 16 12
NEXIUM 191 118 16 21
LOSARTAN-HYDROCHLOROTHIAZIDE 181 147 18 38
TRAMADOL HCL 176 138 19 16
METOPROLOL SUCCINATE 174 156 20 15
SERTRALINE HCL 159 140 21 26
WARFARIN SODIUM 158 151 22 20
AZITHROMYCIN 152 97 23 40
KLOR-CON M20 146 136 24 47
FENOFIBRATE 133 109 25 59
POTASSIUM CHLORIDE 133 94 25 19
CARISOPRODOL 130 74 R 27 89
AMITRIPTYLINE HCL 130 110 R 27 61
CITALOPRAM HBR 123 89 29 24
NAMENDA 122 122 30 45
CLONIDINE HCL 119 105 31 50
ALENDRONATE SODIUM 117 116 32 34
CRESTOR 110 104 33 17
ALLOPURINOL 109 101 34 29
DIGOXIN 108 108 35 55
FLUOXETINE HCL 105 68 36 62
CLOPIDOGREL 101 89 37 30
GLIPIZIDE ER 100 93 38 68
TAMSULOSIN HCL 99 78 39 36
NOVOLOG MIX 70-30 FLEXPEN 98 55 40 185
PANTOPRAZOLE SODIUM 96 85 41 44
DILTIAZEM ER 94 94 42 121
PLAVIX 93 86 43 43
TRIAMTERENE-HCTZ 87 51 44 53
RANITIDINE HCL 81 80 45 25
FLUTICASONE PROPIONATE 78 55 46 32
GLIPIZIDE XL 74 71 47 83
MECLIZINE HCL 73 52 48 113
LABETALOL HCL 71 67 49 169
INSULIN SYRINGE 71 48 49 77
ZETIA 69 58 51 66
LANTUS 69 48 51 54
ATENOLOL 69 66 51 22
NOVOLIN 70-30 66 43 54 154
COUMADIN 65 65 55 285
CYCLOBENZAPRINE HCL 62 14 R 56 65
DONEPEZIL HCL 61 61 57 33
BENAZEPRIL HCL 60 41 58 35
CIPROFLOXACIN HCL 58 50 59 60
MELOXICAM 56 49 60 31
ROPINIROLE HCL 56 30 60 96
PROBENECID 56 56 60 351
DIOVAN 56 49 60 28
PROAIR HFA 54 17 64 57
ENALAPRIL MALEATE 54 40 64 81
ESCITALOPRAM OXALATE 53 42 66 67
METHYLPREDNISOLONE 51 38 67 120
PEN NEEDLE 51 36 67 100
DOXAZOSIN MESYLATE 51 51 67 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.